Quote | EQRx Inc. (NASDAQ:EQRX)
Last: | $2.34 |
---|---|
Change Percent: | -2.14% |
Open: | $2.39 |
Close: | $2.34 |
High: | $2.42 |
Low: | $2.32 |
Volume: | 16,554,640 |
Last Trade Date Time: | 11/08/2023 03:00:00 am |
News | EQRx Inc. (NASDAQ:EQRX)
2024-02-01 16:02:50 ET Summary Revolution Medicines, Inc. has interesting science and early positive data. However, their market cap is too high for a company such as Revolution Medicines. Their R&D expenses are very high. The EQRx, Inc. deal is highly interesting, but...
2023-11-14 16:01:42 ET More on EQRx, Globalstar, etc. Globalstar: The Positives And Negatives Weigh Into A Hold Rating Revolution Medicines: A March Halted By 'Lackluster' ESMO Readout SoftBank Group Corp. (SFTBY) Q2 2023 Earnings Call Transcript Revolu...
Message Board Posts | EQRx Inc. (NASDAQ:EQRX)
Subject | By | Source | When |
---|---|---|---|
Yep nine easy here | pennypauly | investorshub | 12/22/2021 5:04:59 PM |
$EQRX New IPO$ RSI Oversold Under 10 | Stockexpertpro | investorshub | 12/22/2021 4:01:33 PM |
They have the same drug that AstraZeneca uses | pennypauly | investorshub | 12/20/2021 2:39:57 PM |
News, Short Squeeze, Breakout and More Instantly...
EQRx Inc. Company Name:
EQRX Stock Symbol:
NASDAQ Market:
Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...
REDWOOD CITY, Calif. and CAMBRIDGE, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (NASDAQ:RVMD), a clinical-stage oncology...
REDWOOD CITY, Calif. and CAMBRIDGE, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, and EQRx, Inc. (Nasdaq: EQRX), announced that earlier today, at their respective specia...